HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Elizabeth Arden Q3

This article was originally published in The Rose Sheet

Executive Summary

Skin care sales advanced 20% and color cosmetics sales were up 28% in the third quarter (ended Oct. 25) on the strength of product innovation and new advertising initiatives, Elizabeth Arden reports during Dec. 5 analyst call. Net revenue in Q3 increased 2.1% to $321.3 mil., while earnings were up 3.2% to $38.9 mil. Arden is "optimistic" about sales for the holiday season given positive early indications; sell through for holiday gift sets are already 10% ahead of last year, firm notes. Arden projects top line growth of about 6% and earnings per share growth of about 20% next year...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011729

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel